Result of Tender offer

Reckitt Benckiser Successfully Completes Tender Offer for Shares of Schiff Nutrition

SLOUGH, England, Dec. 17, 2012  -- Reckitt Benckiser Group plc ("Reckitt 
Benckiser" or "RB") (LSE: RBL) announced today the successful completion of the tender offer 
(the "Offer") made by Reckitt Benckiser's indirect wholly-owned subsidiary Ascot Acquisition 
Corp. for all of the outstanding shares of Class A common stock and Class B common stock of 
Schiff Nutrition International, Inc. ("Schiff Nutrition") (NYSE: SHF) at a purchase price of $42.00 
per share, net to the seller in cash, without interest, less any applicable withholding taxes as 
specified in the Offer to Purchase filed by Ascot Acquisition Corp. with the Securities and 
Exchange Commission on November 27, 2012. The Offer expired at 11:59 p.m., New York City 
time, on Friday, December 14, 2012.

According to the final report of the depositary for the Offer, as of the expiration of the Offer, a total 
of 28,745,180 shares of Schiff Nutrition common stock were validly tendered and not withdrawn 
prior to the expiration of the Offer, which represent approximately 96.266% of all outstanding 
shares of Schiff Nutrition common stock and 90.137% of all outstanding shares of Schiff Nutrition 
common stock on a fully-diluted basis. In addition, 397,714 shares of Schiff Nutrition common 
stock have been delivered pursuant to the guaranteed delivery procedures. The aggregate number 
of shares validly tendered and not properly withdrawn pursuant to the Offer exceeds the "minimum 
condition" and, accordingly, Ascot Acquisition Corp. accepted for payment all such shares in 
accordance with the terms of the Offer and will promptly pay for such shares in accordance with 
the terms of the Offer.

In accordance with that certain Agreement and Plan of Merger, dated as of November 21, 2012 
(the "Merger Agreement"), by and among the Schiff Nutrition, Reckitt Benckiser LLC, Ascot 
Acquisition Corp. and, solely for the purposes specified in the Merger Agreement, Reckitt 
Benckiser, following consummation of the Offer, Ascot Acquisition Corp. intends to effect a 
"short-form" merger under applicable Delaware law, at which time Schiff Nutrition will become an 
indirect wholly owned subsidiary of Reckitt Benckiser. All outstanding shares of common stock of 
Schiff Nutrition, other than shares held by Schiff Nutrition, Reckitt Benckiser LLC, Ascot 
Acquisition Corp. or any of their respective wholly-owned subsidiaries, or by Schiff Nutrition 
stockholders who are entitled to and properly exercise appraisal rights under Delaware law, will 
be canceled and converted into the right to receive cash equal to the $42.00 Offer price per share, 
net in cash, without interest, less any applicable withholding taxes. In addition, upon completion 
of the merger, the Class A common stock of Schiff Nutrition will cease to be traded on the NYSE.

Forward-Looking Statements

Statements herein regarding the proposed transaction between Reckitt Benckiser and Schiff, 
future financial and operating results and any other statements about future expectations 
constitute "forward looking statements." These forward looking statements may be identified by 
words such as "believe," "expects," "anticipates," "projects," "intends," "should," "estimates" or 
similar expressions. Such statements are based upon current beliefs and expectations and are 
subject to significant risks and uncertainties. There are a number of important factors that could 
cause actual results or events to differ materially from those indicated by such forward looking 
statements. We believe these forward-looking statements are reasonable; however, undue 
reliance should not be placed on any forward-looking statements, which are based on current 
expectations. All written and oral forward-looking statements attributable to us or persons acting 
on our behalf are qualified in their entirety by these cautionary statements. Further, forward-
looking statements speak only as of the date they are made, and we undertake no obligation to 
update or revise forward-looking statements to reflect changed assumptions, the occurrence of 
unanticipated events or changes to future operating results over time unless required by law.

Investor & Analyst Contacts:

Reckitt Benckiser (RB)  
United Kingdom 
Richard Joyce  
Director, Investor Relations  
[phone]  
 
Media Contacts: 
United States 
Sard Verbinnen & Co ([phone])  
Jim Barron  
Jared Levy  
Brooke Gordon  
 
United Kingdom 
Reckitt Benckiser (RB)  
Andraea Dawson-Shepherd  
SVP, Global Corporate Communication & Affairs  
[phone]